Preclinical studies have shown that the transfection of proapoptotic genes such as wild-type p53, Bax, and Gadd153 into esophageal and gastric cancer cells increases their sensitivity to anticancer drugs [119,121,149]. This evidence concerns the gene DDIT3 and gastric cancer.